isoproterenol has been researched along with Cell Transformation, Neoplastic in 17 studies
Isoproterenol: Isopropyl analog of EPINEPHRINE; beta-sympathomimetic that acts on the heart, bronchi, skeletal muscle, alimentary tract, etc. It is used mainly as bronchodilator and heart stimulant.
isoprenaline : A secondary amino compound that is noradrenaline in which one of the hydrogens attached to the nitrogen is replaced by an isopropyl group. A sympathomimetic acting almost exclusively on beta-adrenergic receptors, it is used (mainly as the hydrochloride salt) as a bronghodilator and heart stimulant for the management of a variety of cardiac disorders.
Cell Transformation, Neoplastic: Cell changes manifested by escape from control mechanisms, increased growth potential, alterations in the cell surface, karyotypic abnormalities, morphological and biochemical deviations from the norm, and other attributes conferring the ability to invade, metastasize, and kill.
| Excerpt | Relevance | Reference |
|---|---|---|
| " In the present study, however, changes in intracellular cyclic AMP level in several lines of cultured cells (normal 3T3 and SV40 and polyomavirus-transformed 3T3 cells; 3T6, C6 GLIOMA, MOUSE L, and Novikoff rat hepatoma cells) by treatment with papaverine, prostaglandine E1 or isoproterenol did not correlate with the inhibition of the uridine, hypoxanthine or deoxyglucose transport rates by these chemicals." | 3.65 | Cyclic AMP, membrane transport and cell division. I. Effects of various chemicals on cyclic AMP levels and rate of transport of neucleosides, hypoxanthine and deoxyglucose in several lines of cultured cells. ( Plagemann, PG; Sheppard, JR, 1975) |
| "Isoproterenol (10(-6) M) was applied for 20 min after 2." | 1.32 | Long term inhibition by estradiol or progesterone of melatonin secretion after administration of a mammary carcinogen, the dimethyl benz(a)anthracene, in Sprague-Dawley female rat; inhibitory effect of Melatonin on mammary carcinogenesis. ( De Jonage-Canonico, MB; Kerdelhué, B; Lenoir, V; Martin, A; Scholler, R, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (52.94) | 18.7374 |
| 1990's | 7 (41.18) | 18.2507 |
| 2000's | 1 (5.88) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| De Jonage-Canonico, MB | 1 |
| Lenoir, V | 1 |
| Martin, A | 1 |
| Scholler, R | 1 |
| Kerdelhué, B | 1 |
| Reilly, TM | 1 |
| McHugh, EM | 1 |
| Blecher, M | 1 |
| Higashida, H | 1 |
| Miki, N | 1 |
| Tanaka, T | 1 |
| Kato, K | 1 |
| Nakano, T | 1 |
| Nagatsu, T | 1 |
| Kano-Tanaka, K | 1 |
| Dardick, I | 1 |
| Dardick, AM | 1 |
| MacKay, AJ | 1 |
| Pastolero, GC | 1 |
| Gullane, PJ | 1 |
| Burford-Mason, AP | 1 |
| Schimmer, BP | 1 |
| Kwan, WK | 1 |
| Tsao, J | 1 |
| Qiu, R | 1 |
| Chedeville, A | 1 |
| Mirossay, L | 1 |
| Chastre, E | 1 |
| Hurbain-Kosmath, I | 1 |
| Lopez, M | 1 |
| Gespach, C | 1 |
| Brightling, CE | 1 |
| Baker, AJ | 1 |
| Fuller, RW | 1 |
| Sheppard, JR | 1 |
| Plagemann, PG | 1 |
| Makarski, JS | 1 |
| Niles, RM | 1 |
| Aiyar, N | 1 |
| Mattern, MR | 1 |
| Hofmann, GA | 1 |
| Edwards, RM | 1 |
| Nambi, P | 1 |
| Wu, YY | 1 |
| Lin, MC | 1 |
| Moudry, R | 1 |
| Porzig, H | 1 |
| Garte, SJ | 1 |
| Levitzki, A | 1 |
| Rudick, J | 1 |
| Pastan, I | 1 |
| Vass, WC | 1 |
| Lowy, DR | 1 |
| Marks, F | 1 |
| Grimm, W | 1 |
| Krieg, L | 1 |
| Abell, CW | 1 |
| Monahan, TM | 1 |
| Levine, RL | 1 |
| Hoogenraad, NJ | 1 |
| Kretchmer, N | 1 |
2 reviews available for isoproterenol and Cell Transformation, Neoplastic
| Article | Year |
|---|---|
The role of adenosine 3',5'-cyclic monophosphate in the regulation of mammalian cell division.
Topics: Adenylyl Cyclases; Animals; Bucladesine; Cell Division; Cell Line; Cell Transformation, Neoplastic; | 1973 |
A review: biological and clinical aspects of pyrimidine metabolism.
Topics: Ammonia; Animals; Cats; Cell Transformation, Neoplastic; Cytidine; Glucose; Humans; Isoproterenol; L | 1974 |
15 other studies available for isoproterenol and Cell Transformation, Neoplastic
| Article | Year |
|---|---|
Long term inhibition by estradiol or progesterone of melatonin secretion after administration of a mammary carcinogen, the dimethyl benz(a)anthracene, in Sprague-Dawley female rat; inhibitory effect of Melatonin on mammary carcinogenesis.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Adrenergic beta-Agonists; Animals; Antioxidants; Carcinogens; Carc | 2003 |
Interaction of guanine nucleotides with adenylate cyclase in normal and spontaneously transformed RL-RP-C cloned rat hepatocytes.
Topics: Adenylyl Cyclases; Animals; Cell Transformation, Neoplastic; Cholera Toxin; Clone Cells; Dose-Respon | 1981 |
Receptor-associated changes of the catecholamine-sensitive adenylate cyclase in glioma cells doubly transformed with Moloney sarcoma virus.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adenosine Triphosphate; Adenylyl Cyclases; Animals; Cell Transf | 1982 |
Pathobiology of salivary glands. IV. Histogenetic concepts and cycling cells in human parotid and submandibular glands cultured in floating collagen gels.
Topics: Cell Adhesion; Cell Count; Cell Cycle; Cell Division; Cell Transformation, Neoplastic; Cells, Cultur | 1993 |
Adrenocorticotropin-resistant mutants of the Y1 adrenal cell line fail to express the adrenocorticotropin receptor.
Topics: Adenylyl Cyclases; Adrenal Cortex Neoplasms; Adrenocorticotropic Hormone; Animals; Blotting, Souther | 1995 |
Interaction of VIP, PACAP and related peptides in normal and leukemic human monocytes and macrophages.
Topics: Adenylyl Cyclases; Cell Differentiation; Cell Transformation, Neoplastic; Colforsin; Cyclic AMP; Enz | 1993 |
Isoprenaline inhibits thromboxane B2 release from U937 cells.
Topics: Cell Transformation, Neoplastic; Dose-Response Relationship, Drug; Flurbiprofen; Humans; Isoproteren | 1993 |
Cyclic AMP, membrane transport and cell division. I. Effects of various chemicals on cyclic AMP levels and rate of transport of neucleosides, hypoxanthine and deoxyglucose in several lines of cultured cells.
Topics: Animals; Biological Transport, Active; Bucladesine; Carcinoma, Hepatocellular; Cell Division; Cell L | 1975 |
Loss of adenylate cyclase hormonal sensitivity in chemically transformed epithelial cells.
Topics: Adenylyl Cyclases; Catecholamines; Cell Count; Cell Line; Cell Transformation, Neoplastic; Cyclic AM | 1978 |
Down-regulation of CGRP-mediated cAMP accumulation in ras-transformed 3T3 fibroblasts.
Topics: 3T3 Cells; Animals; Calcitonin Gene-Related Peptide; Cell Line, Transformed; Cell Transformation, Ne | 1992 |
Induction of differentiation in v-Ha-ras-transformed MDCK cells by prostaglandin E2 and 8-bromo-cyclic AMP is associated with a decrease in steady-state level of inositol 1,4,5-trisphosphate.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Animals; Cell Differentiation; Cell Line; Cell Transformatio | 1990 |
Regulation of beta-adrenergic responses during in vitro differentiation of mouse erythroleukemia cells.
Topics: Animals; Catecholamines; Cell Membrane; Cell Transformation, Neoplastic; Colforsin; Cyclic AMP; Dime | 1990 |
Differential effects of phorbol ester on the beta-adrenergic response of normal and ras-transformed NIH3T3 cells.
Topics: Animals; Base Sequence; Cell Line; Cell Transformation, Neoplastic; Cyclic AMP; DNA, Neoplasm; Fibro | 1985 |
Adenylate cyclase activity of NIH 3T3 cells morphologically transformed by ras genes.
Topics: Adenylyl Cyclases; Alprostadil; Animals; Cell Line; Cell Transformation, Neoplastic; Cell Transforma | 1986 |
Disturbance by tumor promotors of epidermal growth control (chalone mechanism).
Topics: Alcohols; Animals; Carcinogens; Cell Division; Cell Transformation, Neoplastic; Croton Oil; Cyclic A | 1972 |